These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2592773)

  • 21. Anti-galactosyl antibodies that react with unmodified agarose: a potential source of artifacts in immunoaffinity chromatography.
    Osborn AH; Kelleher M; Handman E; Goding JW
    Anal Biochem; 1994 Mar; 217(2):181-4. PubMed ID: 8203745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes.
    Scott P; Pearce E; Natovitz P; Sher A
    J Immunol; 1987 Jul; 139(1):221-7. PubMed ID: 3495599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infectivity of Leishmania braziliensis promastigotes is dependent on the increasing expression of a 65,000-dalton surface antigen.
    Kweider M; Lemesre JL; Darcy F; Kusnierz JP; Capron A; Santoro F
    J Immunol; 1987 Jan; 138(1):299-305. PubMed ID: 3782801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trypanosoma cruzi tubulin eliminated in the urine of the infected host.
    Bertot GM; Corral RS; Fresno M; Rodríguez C; Katzin AM; Grinstein S
    J Parasitol; 1998 Jun; 84(3):608-14. PubMed ID: 9645865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The involvement of the major surface glycoprotein (gp63) of Leishmania promastigotes in attachment to macrophages.
    Russell DG; Wilhelm H
    J Immunol; 1986 Apr; 136(7):2613-20. PubMed ID: 3950420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
    Sadick MD; Locksley RM; Tubbs C; Raff HV
    J Immunol; 1986 Jan; 136(2):655-61. PubMed ID: 3079789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cloning, sequencing, and expression of the PSA genes from Leishmania infantum.
    Jiménez-Ruiz A; Boceta C; Bonay P; Requena JM; Alonso C
    Eur J Biochem; 1998 Jan; 251(1-2):389-97. PubMed ID: 9492309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of two integral membrane proteins of Plasmodium falciparum.
    Smythe JA; Coppel RL; Brown GV; Ramasamy R; Kemp DJ; Anders RF
    Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5195-9. PubMed ID: 3293051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant expression, purification and biochemical characterization of a superoxide dismutase from Entamoeba histolytica.
    Bruchhaus I; Brattig NW; Tannich E
    Arch Med Res; 1992; 23(2):27-9. PubMed ID: 1340312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variants of a Leishmania surface antigen derived from a multigenic family.
    Murray PJ; Spithill TW
    J Biol Chem; 1991 Dec; 266(36):24477-84. PubMed ID: 1761547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. cDNA sequence analysis of a 29-kDa cysteine-rich surface antigen of pathogenic Entamoeba histolytica.
    Torian BE; Flores BM; Stroeher VL; Hagen FS; Stamm WE
    Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6358-62. PubMed ID: 2201027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipophosphoglycan of Leishmania major that vaccinates against cutaneous leishmaniasis contains an alkylglycerophosphoinositol lipid anchor.
    McConville MJ; Bacic A; Mitchell GF; Handman E
    Proc Natl Acad Sci U S A; 1987 Dec; 84(24):8941-5. PubMed ID: 3480520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for a phosphatidylinositol anchor in glycolipid antigens of Leishmania major.
    Sevlever D; Londner MV; Rosen G
    Biochem Int; 1989 Jul; 19(1):59-66. PubMed ID: 2550007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of the C-terminal region of 70 kDa heat shock protein from Leishmania (Viannia) braziliensis as a target for the humoral immune response.
    Amorim AG; Carrington M; Miles MA; Barker DC; de Almeida ML
    Cell Stress Chaperones; 1996 Sep; 1(3):177-87. PubMed ID: 9222603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of integral membrane proteins of Leishmania major by Triton X-114 fractionation and analysis of vaccination effects in mice.
    Murray PJ; Spithill TW; Handman E
    Infect Immun; 1989 Jul; 57(7):2203-9. PubMed ID: 2731987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An antigenically distinct lipophosphoglycan on amastigotes of Leishmania major.
    Glaser TA; Moody SF; Handman E; Bacic A; Spithill TW
    Mol Biochem Parasitol; 1991 Apr; 45(2):337-44. PubMed ID: 1710036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cloning and expression in Escherichia coli of cDNAs encoding a 31-kilodalton surface antigen of Sarcocystis muris.
    Eschenbacher KH; Sommer I; Meyer HE; Mehlhorn H; Rüger W
    Mol Biochem Parasitol; 1992 Jul; 53(1-2):159-67. PubMed ID: 1501635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural analysis of glycosyl-phosphatidylinositol antigens of Leishmania major.
    Rosen G; Påhlsson P; Londner MV; Westerman ME; Nilsson B
    J Biol Chem; 1989 Jun; 264(18):10457-63. PubMed ID: 2525125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification, characterisation and genomic cloning of a O-linked N-acetylglucosamine-containing cytoplasmic Leishmania glycoprotein.
    Handman E; Barnett LD; Osborn AH; Goding JW; Murray PJ
    Mol Biochem Parasitol; 1993 Nov; 62(1):61-72. PubMed ID: 8114827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The heterogeneity of Leishmania cell-surface antigens.
    Hernández AG; Payares G; Misle A; Dagger F
    Parasitol Res; 1989; 75(8):583-8. PubMed ID: 2771925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.